NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that its fourth quarter revenues fell 1 percent year over year on lower assay sales.

Total revenues for the three months ended Dec. 31, 2013, were $55.2 million, down from $55.5 million in the fourth quarter of 2012. The results fell short of the consensus Wall Street estimate of $56.6 million in revenues for the quarter.

By segment, assays and related product revenue fell 25 percent to $19.5 million from $25.9 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.